• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
US Proton Therapy Outlook: Market Opportunities - Product Image

US Proton Therapy Outlook: Market Opportunities

  • ID: 2848279
  • May 2014
  • Region: United States
  • 70 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Hitachi
  • IBA
  • Mevion Medical Systems
  • Varian
  • MORE

In the face of an alarmingly rising incidences of cancer and limited treatment options, physicians are being forced to look for treatments beyond the conventional ones. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton therapy is limited for many patients due to the low number of proton therapy centers. Hence, many research institutes and hospitals are now investing in proton therapy to make it more accessible to patients.

According to the “US Proton Therapy Outlook: Market Opportunities” by the author, the United States will be home to almost 29 such centers by 2018, a number which is almost double the current figure. Consequently, the market will breach the Billion dollar mark to attain revenue of US$ 1.19 Billion by 2018. The following 70 pages report provides an insight into the cancer demographics of US and the various possible causes for a high incidence there. The document covers the historical trend (2008-2013) of cancer incidences, deaths and prevalence along with state-wide and site-wide cancer incidences in the country.

Based READ MORE >

FEATURED COMPANIES

  • Hitachi
  • IBA
  • Mevion Medical Systems
  • Varian
  • MORE

1. Analyst View

2. Research Methodology

3. US Cancer Demographics
3.1 Incidence by State
3.2 Incidence by Site

4. Current Radiation Therapies
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Proton Therapy
4.6.1 Why Proton Therapy?

5. Components of a Standard Proton Therapy Center
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource

6. US Proton Therapy Market Outlook to 2018
6.1 Current Market Size and Future Growth
6.2 Potential Patients by State (2013 & 2018)
6.2.1 Market Penetration
6.3 Analysis of Existing and Forthcoming Players
6.3.1 Service Providers
6.3.2 Equipment Providers
6.4 Opportunity Assessment
6.5 Market Trends
6.5.1 Number of Treatment Rooms
6.5.2 Type of Proton Accelerator

7. Reimbursement Scenario

8. Industry Drivers and Restraints
8.1 Drivers
8.2 Restraints

9. Competitive Landscape and Strategic Analysis
9.1 IBA
9.2 Hitachi
9.3 Mevion Medical Systems
9.4 Varian

List of Tables
Table 3-1: Cancer Incidence by State (Million), 2008-2013
Table 3-2: Cancer Incidence by Site (Million), 2008-2013
Table 6-1: State-wide Potential Patients for Proton Therapy (2013)
Table 6-2: State-wide Potential Patients for Proton Therapy (2018)
Table 6-3: Proton Therapy Centers (2013)
Table 6-4: Upcoming Proton Therapy Centers (2014 to 2018)
Table 6-5: Market Share of Service Providers (2018)
Table 6-6: Proton Therapy Equipment Providers with number of Installations till 2013
Table 6-7: Proton Therapy Equipment Providers with Number of Installations by 2018
Table 6-8: Shortage of Proton Therapy Centers, 2018
Table 9-1: IBA - Proton Therapy Products and Services
Table 9-2: IBA - Key Financials (Million Euro), 2011-2013
Table 9-3: IBA - Existing and Upcoming Proton Therapy Installations
Table 9-4: IBA - Strengths and Weaknesses
Table 9-5: Hitachi - Key Financials (Billion US$), 2011-2013
Table 9-6: Hitachi - Existing and Upcoming Proton Therapy Installations
Table 9-7: Hitachi - Strengths and Weaknesses
Table 9-8: Mevion - Existing and Upcoming Proton Therapy Installations
Table 9-9: Mevion - Strengths and Weaknesses
Table 9-10: Varian - Proton Therapy Products and Services
Table 9-11: Varian - Key Financials (Billion US$), 2011-2013
Table 9-12: Varian: Proton Therapy Installations
Table 9-13: Varian - Strengths and Weaknesses

List of Figures
Figure 3-1: Cancer Incidence (Million), 2008-2013
Figure 3-2: Cancer Mortality (‘000), 2008-2013
Figure 3-3: Cancer Prevalence (Million), 2008-2013
Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: Proton Therapy Market (Million US$), 2013-2018
Figure 6-2: Share of Proton Therapy Market in Potential Market (2013)
Figure 6-3: Share of Proton Therapy Market in Potential Market (2018)
Figure 6-4: Market Share of Service Providers (2013)
Figure 6-5: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2013)
Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2018)
Figure 6-7: Demand of Proton Therapy Centers, 2013 & 2018
Figure 6-8: Shortage of Proton Therapy Centers (2013 & 2018)
Figure 6-9: Proton Therapy Center by Number of Treatment Rooms (2013 & 2018)
Figure 6-10: Proton Therapy Center by Type of Proton Accelerator (2013 & 2018)
Figure 9-1: IBA: Breakdown of Revenue by Activity (2013)

- Hitachi
- IBA
- Mevion Medical Systems
- Varian

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos